Literature DB >> 1632942

Differential effect of guanethidine on dopamine and norepinephrine in rat peripheral tissues.

R Favre-Maurice1, M De Haut, Y Dalmaz, L Peyrin.   

Abstract

The changes of dopamine (DA) and norepinephrine (NE) were investigated in rat peripheral tissues after guanethidine treatment (50 mg/kg i.p. five days each week) during one week (group 1, n = 10, five injections) and during 2.5 weeks (group 2, n = 8, 13 injections). Guanethidine greatly reduced NE levels in all the analyzed tissues but only partially depleted DA in kidney, bladder, stomach, intestine, lung and liver and in sympathetic ganglia. The differential pattern of changes between DA and NE induced by guanethidine suggests that peripheral DA is distributed in several neuronal or non-neuronal pools, whose presence, nature and contribution varies in the different tissues. Both noradrenergic cell bodies and small intensely fluorescent cells (SIF cells) can contribute to the DA in the superior cervical ganglion. Noradrenergic neurons seem to be the main sources of DA in seminal vesicles, vas deferens, heart and spleen. In addition to noradrenergic nerves, extraneuronal sources could account for a meaningful portion of DA in kidney, gastrointestinal tract, lung and liver. The bladder is the peripheral tissue where DA exhibits the highest resistance to the neurotoxin. Accordingly, these tissues may provide meaningful sources of non-precursor DA pools.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1632942     DOI: 10.1007/bf01244817

Source DB:  PubMed          Journal:  J Neural Transm Gen Sect


  36 in total

1.  Adrenergic and cholinergic innervation of the rag urinary bladder.

Authors:  P Alm; M Elmér
Journal:  Acta Physiol Scand       Date:  1975-05

2.  Two patterns of dopa decarboxylase immunoreactivity in sympathetic axons supplying rat renal cortex.

Authors:  M Ferguson; C Bell
Journal:  Ren Physiol Biochem       Date:  1991

3.  Evaluation of the permanent sympathectomy produced by the administration of guanethidine to adult rats.

Authors:  E M Johnson; F O'Brien
Journal:  J Pharmacol Exp Ther       Date:  1976-01       Impact factor: 4.030

Review 4.  Dopamine release from sympathetic nerve terminals.

Authors:  C Bell
Journal:  Prog Neurobiol       Date:  1988       Impact factor: 11.685

5.  Effects of chronic intracranial injection of low and high concentrations of guanethidine in the rat.

Authors:  B K Evans; G Singer; S Armstrong; P E Saunders; G Burnstock
Journal:  Pharmacol Biochem Behav       Date:  1975 Mar-Apr       Impact factor: 3.533

6.  Peripheral origin of plasma dopamine.

Authors:  S Yoneda; H Tomioka; M Fukuyama; L C Lee; I Iyota; H Okajima; A Inoue; S Sasaki; K Takeda; H Takahashi
Journal:  Jpn Circ J       Date:  1985-09

7.  Catabolism of endogenous dopamine in peripheral tissues: is there an independent role for dopamine in peripheral neurotransmission?

Authors:  Z Lacković; M Relja; N H Neff
Journal:  J Neurochem       Date:  1982-05       Impact factor: 5.372

8.  Peripheral distribution of free dopamine and its metabolites in the rat.

Authors:  R Favre; M de Haut; Y Dalmaz; J M Pequignot; L Peyrin
Journal:  J Neural Transm       Date:  1986       Impact factor: 3.575

9.  Dietary induced changes in catecholamine metabolites in rat urine.

Authors:  J M Cottet-Emard; L Peyrin; J Bonnod
Journal:  J Neural Transm       Date:  1980       Impact factor: 3.575

View more
  2 in total

1.  Catecholamine-synthesizing enzymes in the rat stomach.

Authors:  N Bäck; M Ahonen; S Soinila; E Kivilaakso; T Kiviluoto
Journal:  Histochem Cell Biol       Date:  1995-07       Impact factor: 4.304

2.  The Influence of an Adrenergic Antagonist Guanethidine on the Distribution Pattern and Chemical Coding of Caudal Mesenteric Ganglion Perikarya and Their Axons Supplying the Porcine Bladder.

Authors:  Agnieszka Bossowska; Ewa Lepiarczyk; Paweł Janikiewicz; Barbara Wasilewska; Urszula Mazur; Włodzimierz Markiewicz; Mariusz Majewski
Journal:  Int J Mol Sci       Date:  2021-05-05       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.